Aneurysm Wall Histology Registry
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of this prospective registry is to determine if patients harboring intracranial aneurysms have any predictive markers between aneurysm wall tissue, cerebrospinal fluid and blood plasma.
Full description
To design a registry to evaluate the wall of intracranial aneurysms during open surgical clipping by direct photographic appearance, wall biopsy samples, CSF and blood plasma fluid collection (Interleukins; IL-8/ Matrix Metalloproteinase; MMP-9) for complete evaluation and comparison.
The focus of the registry will be to determine the presence of aneurysmal wall defects, mural clot, atherosclerotic and atheroma, wall permeability and delamination. These findings will then be correlated to the collected CSF and blood values to determine if there is any direct features of the aneurysm wall that would predict any of the reported post embolic syndromes. The collected data can also be correlated to the peroperative imaging, (MRI, CT and Angiogram).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patient > 18 years but < 80 years of age
- Patient with an unruptured Intracranial aneurysm 8mm or larger
- Patient that surgical exposure and clipping will be the primary treatment option
Exclusion criteria
-
Any patient that has a ruptured intracranial aneurysm
-
Any Pediatric patients
-
Any patient presenting with any pre-treatment intracranial lesions
- Vascular malformations
- Hemorrhage
- Normal Pressure Hydrocephalus
- Obstructive Hydrocephalus
- White matter disease
- Tumors
- Trauma
- Other vascular type lesions
-
Any meningitis type symptoms
-
Medical or surgical co-morbidities such that the patient's life expectancy is less than 1 year
-
Inability to obtain consent
Trial design
Primary purpose
Allocation
Interventional model
Masking
24 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal